Tumor Metabolome Targeting and Drug Development Tumor Metabolome Targeting and Drug Development
Cancer Drug Discovery and Development

Tumor Metabolome Targeting and Drug Development

    • USD 129.99
    • USD 129.99

Descripción editorial

In this volume, the major metabolic alterations identified in cancer and tumor-associated cells are explored, including discussions of former and emerging approaches to drug development in targeting cancer cell metabolism. 

The metabolic network in cells promotes the generation of both energy and biomass needed for them to grow, divide and differentiate.  However, the metabolism of malignant cells generally varies from that of normal cells.  These differences provide a platform for the discovery of new approaches to targeting potential vulnerabilities in cancer cells for therapeutic options  Some of the significant changes that occur involve ATP production and consumption that modulates the ATP to ADP ratio, hypoxia and the effects of reactive oxygen species on glycolysis, regulation of mitochondrial respiration, induction and suppression of autophagy, and the Warburg effect and “reverse” Warburg effect--these topics and more are discussed in this volume.  

GÉNERO
Técnicos y profesionales
PUBLICADO
2014
7 de enero
IDIOMA
EN
Inglés
EXTENSIÓN
206
Páginas
EDITORIAL
Springer New York
VENDEDOR
Springer Nature B.V.
TAMAÑO
2.5
MB

Otros libros de esta serie

Gene and Cellular Immunotherapy for Cancer Gene and Cellular Immunotherapy for Cancer
2022
Molecular Targeted Radiosensitizers Molecular Targeted Radiosensitizers
2020
The Unfolded Protein Response in Cancer The Unfolded Protein Response in Cancer
2019
Estrogen Receptor and Breast Cancer Estrogen Receptor and Breast Cancer
2018
Innovations for Next-Generation Antibody-Drug Conjugates Innovations for Next-Generation Antibody-Drug Conjugates
2018
Targeting the DNA Damage Response for Anti-Cancer Therapy Targeting the DNA Damage Response for Anti-Cancer Therapy
2018